Clinical Trial: Study of Teprenone in the Treatment of Glucocorticoid-Induced Drug-Related Gastrointestinal Injury

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654049) titled 'Study of Teprenone in the Treatment of Glucocorticoid-Induced Drug-Related Gastrointestinal Injury' on June 10.

Brief Summary: Objective:

To evaluate the efficacy, safety, and adherence of the gastric mucosal protective agent teprenone in the treatment of glucocorticoid-induced drug-related gastrointestinal injury.

Study Design:

This study is a prospective, open-label, randomized controlled trial. The study population consists of patients with systemic lupus erythematosus requiring medium- to high-dose glucocorticoid therapy (30-60 mg/day). Eligible patients are enrolled according to inclusion and exclusion criteria and randomly ...